Jarrod Longcor

2022

In 2022, Jarrod Longcor earned a total compensation of $831.8K as Chief Operating Officer at Cellectar Biosciences, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$175,320
Option Awards$206,435
Salary$450,000
Total$831,755

Longcor received $450K in salary, accounting for 54% of the total pay in 2022.

Longcor also received $175.3K in non-equity incentive plan and $206.4K in option awards.

Rankings

In 2022, Jarrod Longcor's compensation ranked 3,404th out of 5,690 executives tracked by ExecPay. In other words, Longcor earned more than 40.2% of executives.

ClassificationRankingPercentile
All
3,404
out of 5,690
40th
Division
Manufacturing
1,925
out of 3,095
38th
Major group
Chemicals And Allied Products
920
out of 1,406
35th
Industry group
Drugs
859
out of 1,307
34th
Industry
Pharmaceutical Preparations
624
out of 949
34th
Source: SEC filing on April 26, 2024.

Longcor's colleagues

We found two more compensation records of executives who worked with Jarrod Longcor at Cellectar Biosciences in 2022.

2022

James Caruso

Cellectar Biosciences

Chief Executive Officer

2022

Chad Kolean

Cellectar Biosciences

Chief Financial Officer

News

You may also like